Peter Damsbo, MD

Gordon B. Cutler, Jr., M.D.

 

Dr. Cutler is a graduate of Harvard College and Harvard Medical School, and completed internship and residency training in internal medicine (at Barnes Hospital) and a fellowship in endocrinology (at the National Institutes of Health).  Gordon served as Senior Investigator (1978-1983) and Chief, Section on Developmental Endocrinology (1983-1997), at the National Institute of Child Health and Human Development, and then moved to Lilly Research Laboratories (1997-2008) as Medical Director and, later, Distinguished Medical Fellow. 

 

Since 2008 he has been an independent consultant to the biotechnology and pharmaceutical industry in the areas of clinical strategy and late-stage clinical trial design and execution.  His scientific and professional interests have included disorders of growth, puberty, adrenal and parathyroid gland function, and diabetes.  He has published over 280 peer-reviewed papers, and trained numerous adult and pediatric endocrinologists. 

 

Dr. Cutler's research has led to FDA approval of histrelin (for precocious puberty) and ovine corticorelin (for differential diagnosis of Cushing syndrome), and to new FDA-approved indications for human growth hormone (for idiopathic short stature and SHOX gene deficiency).  He led development strategy at Lilly for drugs targeting muscle (e.g., GH, GH secretagogue, SARM, and anti-myostatin), obtained US and EU regulatory advice on treatment of frailty, and co-authored a consensus report on designing RCTs for frailty in the elderly.  He also co-invented a novel, ultra-long-acting basal insulin (basal insulin peglispro, LY 2605541)—for which development was halted for business reasons after phase 3 clinical trials—and led the design of 9 phase 3 trials for Lilly’s inhaled insulin product, which was cancelled for commercialization risk. 

 

Gordon is a member of The Endocrine Society, American Diabetes Association, American College of Physicians (Fellow), American Medical Association, and American Association for the Advancement of Science.  Honors include the US Public Health Service Commendation Medal, Outstanding Service Medal, and Meritorious Service Medal, and Lilly Research Laboratories President’s Award. 

 

 

Leadership List

Officers

G. Alexander Fleming, MD
Executive Chairman

Thomas Seoh
President and Chief Executive Officer

 

Clinical Development

G. Alexander Fleming, MD

Arthur Santora, MD, Ph.D

Brian E. Harvey, MD, Ph.D

Charles Alexander, MD

Giora Davidai, MD

Gordon B. Cutler, Jr., M.D.

Grant Williams, MD

Guenther Karmann, Ph.D

John K. Whisnant, Jr, MD

Michael Trautmann, MD

Peter Damsbo, MD

Richard Paul, MD

Rob Walsh, MD

Simon Bruce, MD

Theo Gana, MD, Ph.D

Todd J. Lorenz, MD

 

Regulatory Affairs

G. Alexander Fleming, MD

Arthur Santora, MD, Ph.D

Asoke Mukherjee, Ph.D

Brian E. Harvey, MD, Ph.D

Catherine Bernard, Ph.D

Dia Hill

Doug Muchmore, MD

Frances Mielach, Ph.D, RP.h

Gabrielle Wiederkehr, MSc

Grant Williams, MD

Joshua Sharlin, Ph.D

Joyce Reyes

Lana Pauls, MPH

Michael Sharp, Ph.D

Scot Faulkner, MPA

 

EU Regulatory

Catherine Bernard, Ph.D

Michael Trautmann, MD

 

Clinical Operations/Project Management

Chris Yun

Diane Paul, MS, RN

Gabrielle Wiederkehr, MSc

Julie Waltz Gerlach, B.S.N., M.P.H., R.A.C.

Lana Pauls, MPH

Lynn Schaich

Susan Manley

 

Pre-Clinical

Asoke Mukherjee, Ph.D

Dave Edwards, Ph.D

Frances Mielach, Ph.D, RP.h

Joy Cavagnaro, Ph.D

Marijke Adams PharmD, Ph.D

Monalisa Chatterji,Ph.D

Virgil Whitehurst, Ph.D

 

CMC, Formulation/Process Development & Sourcing

Anand Khedkar, Ph.D

David Bergstrom, Ph.D

Joyce Reyes

Knut Zellerhoff, Ph.D

Robert Kaster, RPh., ASQ-CQA

 

Medical Device

Michael Sharp, Ph.D

Rob Walsh, MD

 

 QA/QC

Joshua Sharlin, Ph.D

Julie Waltz Gerlach, B.S.N., M.P.H., R.A.C.

Lynn Schaich

Robert Kaster, RPh., ASQ-CQA

 

Medical Writing/Electronic Submissions

Brandon Jones

Dahlia Sperling

Russ Neubauer, Ph.D

Sandor Bernath, Ph.D, MBA

 

Process & Innovation Management

Elizabeth Whalley Buono, BSN, RN, MBA, JD

Scot Faulkner, MPA

 

Commercializing and Business & Corporate Strategy

Lisa Jansa, MBA

Martin Lafontaine

Stephen Casey, MBA

Thomas Seoh

 

Founders

G. Alexander Fleming, MD

Lisa Jansa, MBA